WOBURN, Mass., Nov. 01, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), announced today that the Company plans to release its third quarter 2016 financial results and host a conference call with management after market close on Wednesday, November 9, 2016.
While shareholders participate in the call in listen-only mode, the Company invites shareholders to submit questions by November 7, 2016 for consideration to [email protected] with the subject line: “Questions for Third Quarter Call.” Questions submitted in advance of the call will be reviewed and a certain number of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Wednesday, Nov. 9 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.metabolix.com. In addition, the webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13648037. The replay will be available for 14 days.
About Metabolix
Metabolix, Inc. is winding down its legacy PHA biopolymer business and becoming Yield10 Bioscience. Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing the development of several yield traits in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, MA.
For more information, visit www.metabolix.com. (MBLX-E)
For more information on Yield10 Bioscience, visit Yield10.
Metabolix Contact: Lynne H. Brum, 617-682-4693, [email protected]


TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



